SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-042097
Filing Date
2004-03-15
Accepted
2004-03-15 15:05:48
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1154789
3 SUBSIDIARIES OF CYTOGEN CORPORATION dex21.htm EX-21 2263
4 CONSENT OF KPMG LLP dex231.htm EX-23.1 3055
5 CONSENT OF PRICEWATERHOUSECOOPERS dex232.htm EX-23.2 1761
6 SECTION 302 CERTIFCATION OF CEO dex311.htm EX-31.1 9908
7 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9925
8 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 4648
9 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 4682
10 REPORT OF INDEPENDENT AUDITORS dex991.htm EX-99.1 134713
  Complete submission text file 0001193125-04-042097.txt   1328282
Mailing Address 600 COLLEGE RD EAST CN 5308 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540
Business Address 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

IRS No.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 04669186
SIC: 2834 Pharmaceutical Preparations